Biocon has entered a partnership with Tabuk Pharmaceuticals for the commercialisation of glucagon-like peptide-1 (GLP-1) ...

The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 ...

The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.

Pfizer has announced the withdrawal of all lots of OXBRYTA approved for treating sickle cell disease (SCD) from worldwide ...

The EC has granted marketing authorisation to LEO Pharma’s Anzupgo cream for treating adults with moderate to severe chronic ...

Opioid use disorder (OUD) is a chronic neurological disorder characterised by the compulsive, repeated use of opioids, ...

Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.

Safety processes and regulations apply to custom-made medicines, which differ from traditional pharmacies. Now, however, ...

The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.

Orion has entered a partnership with Aitia to leverage artificial intelligence in drug discovery and simulation in the ...

Phare Bio has received up to $27m from the Advanced Research Projects Agency for Health (ARPA-H) to advance its drug ...

Takeda has secured the Japanese MHLW approval for its FRUZAQLA to treat unresectable advanced or recurrent colorectal cancer ...